Targeting AKR1C3 to Combat Erlotinib Resistance in Lung Cancer
In a groundbreaking study that could reshape the treatment landscape for lung adenocarcinoma, researchers have identified AKR1C3 as a potential ...
In a groundbreaking study that could reshape the treatment landscape for lung adenocarcinoma, researchers have identified AKR1C3 as a potential ...
Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) representing the majority of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine